Page 2 - தீர்ப்பியல்ட் கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தீர்ப்பியல்ட் கண்டுபிடிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தீர்ப்பியல்ட் கண்டுபிடிப்பு Today - Breaking & Trending Today

Syngene Intl Q3 PAT rises 11% YoY to Rs 102 cr


Syngene International gained 0.85% to Rs 616.6 after the drug maker posted a 11.3% rise in consolidated net profit to Rs 102.2 crore on a 12.6% rise in net sales to Rs 584.5 crore in Q3 December 2020 over Q3 December 2019.Consolidated profit before tax stood at Rs 116.5 crore in Q3 December 2020, 9.2% higher than Rs 106.7 crore in Q3 December 2019. Tax expense declined 4% to Rs 14.3 crore in Q3 December 2020 over Q3 December 2019.
The drug manufacturer said its third-quarter revenue growth was driven by a sustained performance from all divisions. Continued focus on cost control measures and improving operational efficiency have underpinned profitability and delivered a strong profit margin. ....

Jonathan Hunt , Syngene International , Deerfield Discovery , Capital Market , Companies Based In Bangalore , Earnings Before Interest , Depreciation And Amortization , Chemical Sectors , Manufacturing Services , Drug Discovery , ஜொனாதன் வேட்டை , தீர்ப்பியல்ட் கண்டுபிடிப்பு , மூலதனம் சந்தை , நிறுவனங்கள் அடிப்படையிலானது இல் பெங்களூர் , இரசாயன துறைகள் , உற்பத்தி சேவைகள் , மருந்து கண்டுபிடிப்பு , உயிரி தொழில்நுட்பவியல் ,

Syngene International's FY21 third-quarter PAT up 11%


Syngene International s FY21 third-quarter PAT up 11%
Syngene International s FY21 third-quarter PAT up 11%
21 January 2021 | News
The company posted quarterly revenue from operations of Rs 585 crore compared to Rs 519 crore in the corresponding quarter of last year
Source credit: Shutterstock
Syngene International Limited has announced its third-quarter FY21 results. The Company posted quarterly revenue from operations of Rs 585 crore compared to Rs 519 crore in the corresponding quarter of last year. EBITDA and PAT for the quarter were both up 11 per cent to Rs 193 crore and Rs 102 crore respectively.
Commenting on the results, Jonathan Hunt, Managing Director and Chief Executive Officer, Syngene International Ltd said, “We are pleased to report third-quarter growth in line with our guidance with revenue from operations growing 13 per cent  while PAT was up 11 per cent. Sustained focus on employee and campus safety helped us maintain near-nor ....

Jonathan Hunt , Syngene International , Syngene International Ltd , Syngene International Limited , Managing Director , Chief Executive Officer , Deerfield Discovery , Q4fy21 Results , Integrated Drug Discovery , ஜொனாதன் வேட்டை , நிர்வகித்தல் இயக்குனர் , தலைமை நிர்வாகி அதிகாரி , தீர்ப்பியல்ட் கண்டுபிடிப்பு , ஒருங்கிணைந்த மருந்து கண்டுபிடிப்பு ,